This study tests new medications developed by pharmaceutical companies to prevent or treat various symptoms and diseases. Past trials have focused on conditions such as diabetic neuropathy, COVID-19 prophylaxis, and smoking cessation.
The study will include participants who meet specific eligibility criteria based on the condition being targeted. Participants will receive either the investigational medication or a placebo, an inactive substance that looks like the medication but does not contain any active ingredients. The number of visits and the study duration will vary depending on the trial.
